Brazil Therapeutic Respiratory Devices Market Report: Market Size & Forecast 2026

The Brazil therapeutic respiratory devices market covers a range of products designed to support patients with chronic and acute respiratory conditions, including chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and respiratory infections. The market in 2025 is valued at approximately $16.15 billion and is projected to grow at a 6.4% annual rate as healthcare infrastructure expands and demand for respiratory care increases. Products in this segment include oxygen concentrators, nebulizers, humidifiers, ventilators, positive airway pressure devices, respiratory masks, and filtration systems.

• •Market valued at approximately $16.15 billion in 2025 with 6.4% CAGR growth expected
• •Products include oxygen concentrators, nebulizers, humidifiers, ventilators, PAP devices, masks, and filters
• •Serves both institutional healthcare settings and growing homecare segments

Rising prevalence of respiratory diseases such as COPD and asthma, worsened by urban air pollution and high rates of smoking in certain demographics, is a primary driver of market expansion. An aging population in Brazil is increasing demand for therapeutic respiratory support, as respiratory conditions become more common with age. Expanding healthcare access through public and private insurance coverage, combined with technological improvements in portable and home-use devices, is further accelerating adoption across the country.

• •High prevalence of COPD, asthma, and respiratory infections linked to pollution and smoking rates
• •Aging population driving greater need for long-term respiratory care solutions
• •Improved insurance coverage and government healthcare initiatives expanding device accessibility

The market is segmented by product type, with oxygen concentrators, nebulizers, and humidifiers representing significant product categories alongside ventilators and positive airway pressure systems. Technology-based segmentation includes electrostatic filtration and HEPA filtration systems, which are important for infection control and air quality in both clinical and home environments. Brazil dominates the therapeutic respiratory devices market within Latin America, with higher per-capita consumption in the Southeast region where major urban centers and healthcare infrastructure are concentrated.

• •Key product categories: oxygen concentrators, nebulizers, humidifiers, ventilators, PAP devices
• •Technology segments include electrostatic filters and HEPA filters for air purification
• •Southeast Brazil leads in market penetration due to concentrated healthcare infrastructure and population

What are the recent trends and outlook?

The market is moving toward portable, lightweight, and digitally connected respiratory devices that enable remote monitoring and telemedicine integration, improving patient outcomes while reducing hospitalization costs. Growing awareness of sleep-disordered breathing is expanding the positive airway pressure devices segment, while COVID-19-era investments in respiratory infrastructure continue to influence procurement patterns. Over the forecast period, home-based respiratory therapy is expected to grow faster than institutional settings as patients and payers favor outpatient care models that reduce overall healthcare expenditure.

• •Rising adoption of portable, connected devices with remote monitoring and telemedicine capabilities
• •Sleep apnea awareness driving expansion of positive airway pressure device segment
• •Homecare respiratory therapy projected to outpace institutional market growth through 2030